70 likes | 289 Views
The management of postmenopausal osteoporosis first focuses on identifying the woman's risk factors, then selecting measures that will reduce modifiable risk factors through lifestyle changes and, if indicated, pharmacologic therapy. . If pharmacologic therapy is indicated . FDA-approved options ar
E N D
1. Osteoporosis New Trends inPrevention and Treatment Prof. Bari Kaplan MD.
. 2-4-2003
2. The management of postmenopausal osteoporosis first focuses on identifying the woman’s risk factors, then selecting measures that will reduce modifiable risk factors through lifestyle changes and, if indicated, pharmacologic therapy.
3. If pharmacologic therapy is indicated FDA-approved options are:
Estrogens (prevention only) according FDA new statement.
Bisphosphonates and Selective estrogen-receptor modulators (prevention and treatment),
Calcitonin (treatment only).
PTH
4. Anti fracture efficacy of the most frequently used treatment of postmenopausal osteoporosis in addition to the effects of calcium or vitamin D supplementation, or both, as derived from placebo controlled randomized trials.
6. Therapeutic Management of Postmenopausal Osteoporosis Therapeutic Management of Postmenopausal Osteoporosis
Therapeutic Management of Postmenopausal Osteoporosis